Connor, Clark & Lunn Investment Management (CC&L)’s Usana Health Sciences USNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.98M | Buy |
97,537
+65,268
| +202% | +$1.99M | 0.01% | 735 |
|
|
2025
Q1 | $870K | Buy |
+32,269
| New | +$870K | ﹤0.01% | 999 |
|
|
2020
Q4 | – | Sell |
-4,923
| Closed | -$363K | – | 1047 |
|
|
2020
Q3 | $363K | Sell |
4,923
-14,680
| -75% | -$1.08M | ﹤0.01% | 764 |
|
|
2020
Q2 | $1.44M | Sell |
19,603
-15,590
| -44% | -$1.14M | 0.01% | 525 |
|
|
2020
Q1 | $2.03M | Buy |
+35,193
| New | +$2.03M | 0.02% | 414 |
|
|
2019
Q3 | – | Sell |
-8,925
| Closed | -$709K | – | 1095 |
|
|
2019
Q2 | $709K | Buy |
8,925
+150
| +2% | +$11.9K | ﹤0.01% | 650 |
|
|
2019
Q1 | $736K | Buy |
+8,775
| New | +$736K | ﹤0.01% | 594 |
|
|
2018
Q2 | – | Sell |
-18,400
| Closed | -$1.58M | – | 1103 |
|
|
2018
Q1 | $1.58M | Sell |
18,400
-4,150
| -18% | -$357K | 0.01% | 422 |
|
|
2017
Q4 | $1.67M | Buy |
22,550
+16,250
| +258% | +$1.2M | 0.01% | 447 |
|
|
2017
Q3 | $364K | Buy |
+6,300
| New | +$364K | ﹤0.01% | 675 |
|
|
2016
Q3 | – | Sell |
-4,200
| Closed | -$234K | – | 921 |
|
|
2016
Q2 | $234K | Sell |
4,200
-3,600
| -46% | -$201K | ﹤0.01% | 717 |
|
|
2016
Q1 | $474K | Sell |
7,800
-4,800
| -38% | -$292K | ﹤0.01% | 580 |
|
|
2015
Q4 | $805K | Buy |
12,600
+1,000
| +9% | +$63.9K | 0.01% | 474 |
|
|
2015
Q3 | $777K | Sell |
11,600
-5,200
| -31% | -$348K | 0.01% | 447 |
|
|
2015
Q2 | $1.15M | Buy |
+16,800
| New | +$1.15M | 0.01% | 315 |
|